Royalty Pharma plc

Ownership Transactions Reported by 24 Insiders

Symbol
RPRX on Nasdaq
Industry
Pharmaceutical Preparations
Location
110 East 59 Th Street, New York, NY

Insiders trading volume in the past year

Royalty Pharma plc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Pablo G. Legorreta CEO, Chairman of the Board, Director $2.59B Nov 5, 2025
Gg 1978 Sicaf Sif S.A. 10%+ Owner $608M Sep 14, 2022
GG 1978 SICAF SIF S.A. - GG Strategic 10%+ Owner $590M Sep 20, 2022
George W. Lloyd EVP, Investments & CLO $290M Nov 5, 2025
Terrance P. Coyne Evp & Cfo $246M -$2.74M -1.1% Nov 17, 2025
Mario Germano Giuliani Director, 10%+ Owner $96M Jun 23, 2023
Avara Management Ltd 10%+ Owner $68.5M Dec 29, 2023
William E. Ford Director $56.4M Jun 30, 2021
Christopher Hite EVP & Vice Chairman $25.7M Nov 5, 2025
James F. Reddoch EVP & Chief Scientific Officer $23.3M Sep 28, 2022
Rory B. Riggs Director $11.6M Feb 20, 2024
Marshall Urist EVP, Research & Investments $9.51M Nov 5, 2025
Gregory Norden Director $7.06M -$1.21M -14.7% Aug 8, 2025
Errol B. Desouza Director $4.83M May 13, 2025
Henry A. Fernandez Director $4.23M Jun 30, 2025
Ted W. Love Director $3.12M May 13, 2025
Catherine M. Engelbert Director $2.95M May 13, 2025
Bonnie L. Bassler Director $2.58M Sep 30, 2025
David C. Hodgson Director $1.84M May 13, 2025
Vlad Coric Director $345K May 13, 2025
Carole Ho Director $284K Jul 31, 2025
Elizabeth H. Weatherman Director $284K Jul 31, 2025
Royalty Pharma plc Director $0 Apr 7, 2025
MGG Strategic SICAF SIF S.A. 10%+ Owner Apr 1, 2022

Recent Insider Transactions by Companies or Individuals for Royalty Pharma plc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.